Robert J. Gould
2023 - Fulcrum Therapeutics
In 2023, Robert J. Gould earned a total compensation of $424.5K as Former Interim President and Chief Executive Officer at Fulcrum Therapeutics, a 259% increase compared to previous year.
Compensation breakdown
| Option Awards | $76,404 |
|---|---|
| Salary | $300,000 |
| Other | $48,097 |
| Total | $424,501 |
Gould received $300K in salary, accounting for 71% of the total pay in 2023.
Gould also received $76.4K in option awards and $48.1K in other compensation.
Rankings
In 2023, Robert J. Gould's compensation ranked 1,807th out of 2,271 executives tracked by ExecPay. In other words, Gould earned more than 20.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,807 out of 2,271 | 20th |
Division Manufacturing | 1,022 out of 1,238 | 17th |
Major group Chemicals And Allied Products | 608 out of 696 | 13th |
Industry group Drugs | 592 out of 667 | 11th |
Industry Pharmaceutical Preparations | 427 out of 481 | 11th |
Source: SEC filing on April 19, 2024.
Gould's colleagues
We found five more compensation records of executives who worked with Robert J. Gould at Fulcrum Therapeutics in 2023.
2023
Alex Sapir
Fulcrum Therapeutics
Chief Executive Officer
2023
Curtis Oltmans
Fulcrum Therapeutics
Chief Legal Officer
2023
Mel Hayes
Fulcrum Therapeutics
Executive Vice President, Patient Affairs
2023
Alan Musso
Fulcrum Therapeutics
Chief Financial Officer
2023
Bryan Stuart
Fulcrum Therapeutics